
|Gene|Status| First BL study |
|:-:|:--:|:-:|
|[ADAMTS5](ADAMTS5)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[ADNP](ADNP)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[AGO4](AGO4)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[ARHGEF1](ARHGEF1)|Tier 2|[Muppidi et al](papers/muppidiLossSignalingGa132014)|
|[B2M](B2M)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[BCL2](BCL2)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[BTG1](BTG1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[C16orf48](C16orf48)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[CARD11](CARD11)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[CARD4](CARD4)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[CCNF](CCNF)|Tier 2|[Abate et al](papers/abateDistinctViralMutational2015)|
|[CD79A](CD79A)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[CD83](CD83)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[CDC27](CDC27)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[CDC73](CDC73)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[CDKN2A](CDKN2A)|Tier 2|[Grande et al](papers/grandeGenomewideDiscoverySomatic2019)|
|[CDKN2C](CDKN2C)|Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|
|[CHD4](CHD4)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[CPXM2](CPXM2)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[CXCR4](CXCR4)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[DHCR7](DHCR7)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[E2F2](E2F2)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[EBF1](EBF1)|Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|
|[EDNRB](EDNRB)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[EHD1](EHD1)|Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|
|[EIF4A1](EIF4A1)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[ELP2](ELP2)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[EPPK1](EPPK1)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[ERAP1](ERAP1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[EXOSC6](EXOSC6)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[FLYWCH1](FLYWCH1)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[GGTLA4](GGTLA4)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[GTSE1](GTSE1)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[HIST1H1B](HIST1H1B)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[HIST1H3D](HIST1H3D)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[HIST1H3I](HIST1H3I)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[HIST1H4J](HIST1H4J)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[HLA-DQB1](HLA-DQB1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[IKZF3](IKZF3)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[IRF8](IRF8)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[KANK2](KANK2)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[KLHL26](KLHL26)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[KMT2C](KMT2C)|Tier 2|[Zhou et al](papers/zhouSporadicEndemicBurkitt2019)|
|[MCL1](MCL1)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[MIR142](MIR142)|Tier 2|[Grande et al](papers/grandeGenomewideDiscoverySomatic2019)|
|[MKI67](MKI67)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[MYO18A](MYO18A)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[NBEAL1](NBEAL1)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[NCOR2](NCOR2)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[NOA1](NOA1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[P2RY2](P2RY2)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[PDCD11](PDCD11)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[PIM1](PIM1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[PLCG2](PLCG2)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[PPP6R2](PPP6R2)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[PRDM1](PRDM1)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[PREX1](PREX1)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[RANBP6](RANBP6)|Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|
|[REV3L](REV3L)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[RNF144B](RNF144B)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[RPL10](RPL10)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[S1PR2](S1PR2)|Tier 2|[Muppidi et al](papers/muppidiLossSignalingGa132014)|
|[SAL3](SAL3)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[TBL1XR1](TBL1XR1)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[TET2](TET2)|Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|
|[TNFRSF14](TNFRSF14)|Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|
|[TOP2A](TOP2A)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[TTN](TTN)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[VWA7](VWA7)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[WDR90](WDR90)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[WHAMM](WHAMM)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[WNK2](WNK2)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[YY1AP1](YY1AP1)|Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|
|[ZAN](ZAN)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[ZBTB7A](ZBTB7A)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|
|[ZFP36L1](ZFP36L1)|Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|
|[ZNF85](ZNF85)|Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|